In the largest trial of its kind, patients receiving oral versus intravenous (IV) antibiotics for fracture-related infections ...

A new treatment for sexually-transmitted diseases seems to be slowing an STI epidemic — but not everyone can get it ...

Doxycycline postexposure prophylaxis (doxyPEP) initiation is associated with decreases in sexually transmitted infections (STIs).

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

For decades it's been said that you need to drink plenty of milk to have strong bones. It's an old wives tale that's done the rounds for years, but you may be wondering if there's any truth in it. To ...

The early rollout of doxyPEP — a dose of the antibiotic doxycycline after sex — has contributed to a decline in sexually ...

“In the meantime, our study suggests that broader implementation of doxyPEP could have tremendous benefits for reducing STI transmission and improving sexual health.” This study provides ...

Researchers found that 19.5% of patients were dispensed doxyPEP, which was associated with older age, longer HIV PrEP use, and a higher proportion of commercial insurance. HealthDay News — Doxycycline ...

Please purchase a subscription to read our premium content. If you have a subscription, please log in or sign up for an account on our website to continue.

A new study indicates resistance to shorter and less toxic drug regimens for multidrug-resistant tuberculosis (MDR-TB) is emerging and spreading between patients.

While the use of PrEP has helped drop the rates of HIV infections, instances of syphilis and chlamydia among queer men have been skyrocketing, but a new study shows that doxyPEP may be the answer to ...